Clinical outcomes of finerenone in heart failure: A systematic review and meta-analysis

doi:10.4330/wjc.v18.i4.118879

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 4

This Article

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (0)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-1) series.

Item

Count

PDF

HTML

Figures (1-3)

Tables (1-1)

Sum=100

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=70

Publishing Process of This Article

Item

Count

Browse

Download

Sum=12

Apr 26, 2026 (publication date) through Apr 14, 2026

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Cardiol. Apr 26, 2026; 18(4): 118879
Published online Apr 26, 2026. doi: 10.4330/wjc.v18.i4.118879

Open in New Tab Full Size Figure Download Figure

Figure 1 PRISMA flowchart of study selection process. RCT: Randomised controlled trial; HF: Heart failure.

Open in New Tab Full Size Figure Download Figure

Figure 2 Efficacy outcomes of finerenone in heart failure. KCCQ: Kansas City Cardiomyopathy Questionnaire.

Open in New Tab Full Size Figure Download Figure

Figure 3 Mechanism of action of finerenone on heart failure. MR: Mineralocorticoid receptor; ROS: Reactive oxygen species.

Citation: Mylavarapu M, Kiyani M, Ndakotsu A, Vats V, Karnan N, Palaparthi EC, Anjum M, Kodali LSM, Jamshed A, Cabrera FEP. Clinical outcomes of finerenone in heart failure: A systematic review and meta-analysis. World J Cardiol 2026; 18(4): 118879
URL: https://www.wjgnet.com/1949-8462/full/v18/i4/118879.htm
DOI: https://dx.doi.org/10.4330/wjc.v18.i4.118879